Finance

Lists
P8A:SGX
Cordlife Group Ltd
SGD 0.12
0.00%
(0.00) 1D
10-р сарын 12, 09:49:20 (GMT+8)  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for P8A...
Mkt. cap
32.37 сая
Avg. vol.
1.32 мян
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53 сая
No. of employees
111
Mkt. cap
32.37 сая
Avg. vol.
1.32 мян
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53 сая
No. of employees
111
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
34 минутын өмнө
What AAON Bears Saw Before The Fall
Trefis
Trefis
·
34 минутын өмнө
1 S&P 500 Stock Hit A 52-Week Low On Friday
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012. Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services. Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn. In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOYiu Pang Fai
Employees111
Founded2001 оны 5-р сарын 2
Headquarters-
SectorHealth care provider
Previous reportsAll values in SGD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
10.21 сая
9.46 сая
8.99 сая
8.30 сая
Cost of goods sold
4.16 сая
4.05 сая
3.78 сая
3.44 сая
Cost of revenue
4.16 сая
4.05 сая
3.78 сая
3.44 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.42 сая
10.52 сая
7.60 сая
6.41 сая
Operating expense
9.29 сая
10.41 сая
7.47 сая
6.36 сая
Total operating expenses
13.45 сая
14.46 сая
11.25 сая
9.80 сая
Operating income
-3.24 сая
-5.00 сая
-2.26 сая
-1.50 сая
Other non operating income
-
-
-
-
EBT including unusual items
-2.33 сая
-4.30 сая
-1.70 сая
-873.00 мян
EBT excluding unusual items
-2.33 сая
-4.38 сая
-1.70 сая
-873.00 мян
Income tax expense
149.00 мян
1.26 сая
19.00 мян
64.00 мян
Effective tax rate
-6.39%
-29.22%
-1.12%
-7.33%
Other operating expenses
-133.00 мян
-111.00 мян
-132.00 мян
-54.00 мян
Net income
-2.48 сая
-5.55 сая
-1.72 сая
-936.00 мян
Net profit margin
-24.32%
-58.72%
-19.13%
-11.28%
Earnings per share
-
-
-
-
Interest and investment income
642.00 мян
589.00 мян
565.00 мян
587.00 мян
Interest expense
-27.00 мян
-34.00 мян
-28.00 мян
-77.00 мян
Net interest expenses
615.00 мян
555.00 мян
537.00 мян
510.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.17 сая
-4.29 сая
-1.33 сая
-621.00 мян
Gain or loss from assets sale
1.00 мян.
220.00 мян
5.00 мян
4.00 мян
AI content may include mistakes. Learn more
Google аппс